Maia Aisicovich Selected Research

Thyrotropin-Releasing Hormone (Protirelin)

1/2021	Cardiac Thyrotropin-releasing Hormone Inhibition Improves Ventricular Function and Reduces Hypertrophy and Fibrosis After Myocardial Infarction in Rats.
11/2020	Cardiovascular and body weight regulation changes in transgenic mice overexpressing thyrotropin-releasing hormone (TRH).
11/2018	Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maia Aisicovich Research Topics

Disease

3	Fibrosis (Cirrhosis) 01/2021 - 11/2018
3	Hypertrophy 01/2021 - 11/2018
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 11/2018
1	Infarction (Infarctions) 01/2021
1	Myocardial Infarction 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 11/2020
1	Cardiotoxicity 11/2020
1	Heart Injuries 11/2020
1	Hypertension (High Blood Pressure) 11/2020
1	Neoplasms (Cancer) 11/2020
1	Heart Diseases (Heart Disease) 11/2020
1	Body Weight (Weight, Body) 11/2020

Drug/Important Bio-Agent (IBA)

3	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 01/2021 - 11/2018
2	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2020
2	CollagenIBA 01/2021 - 11/2018
2	Angiotensin IIIBA 11/2020 - 11/2018
1	Atrial Natriuretic Factor (ANF)IBA 01/2021
1	Ventricular MyosinsIBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	AnthracyclinesIBA 11/2020
1	Pharmaceutical PreparationsIBA 11/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2020
1	Hormones (Hormone)IBA 11/2018